Synthesis and degradation characteristics of salicylic acid-derived poly(anhydride-esters)

Biomaterials

Volumn 21, Issue 19, 2000, Pages 1941-1946

  Erdmann, L ^a   Uhrich, K E ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

Biodegradable; In vitro degradation; pH dependent; Poly(anhydride ester)

Indexed keywords

BIODEGRADATION; CARBOXYLIC ACIDS; DRUG PRODUCTS; HYDROLYSIS; METABOLISM; PH EFFECTS; POLYCONDENSATION; POLYESTERS; SYNTHESIS (CHEMICAL);

POLYANHYDRIDE ESTERS; SALICYLIC ACID;

BIOMATERIALS;

AROMATIC COMPOUND; ESTER; MONOMER; POLY(ANHYDRIDE ESTER); POLYMER; PRODRUG; SALICYLIC ACID; UNCLASSIFIED DRUG;

ARTICLE; BIODEGRADABLE IMPLANT; CONTROLLED STUDY; DEGRADATION; DRUG RELEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROLYSIS; INFRARED SPECTROSCOPY; PH; POLYMERIZATION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SYNTHESIS;

ANHYDRIDES; BIOCOMPATIBLE MATERIALS; ESTERS; HYDROLYSIS; POLYMERS; SALICYLIC ACID;

EID: 0034308353     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(00)00073-9     Document Type: Article

References (21)

1. Liso P., Rebuelta M., Roman J., Gallardo A., Villar A. Polymeric drugs derived from Ibuprofen with improved antiinflammatory profile. J Biomed Mater Res. 32:1996;553-560.
2. Nakamura J., Tagami C., Nishida K., Sasaki H. Development of a prodrug of salicylic acid-L-alanine conjugate, utilizing hydrolysis by rabbit intestinal microorganisms. J Pharma Pharmacol. 44:1992;295-299.
3. Chiba M., Hanes J., Langer R. Controlled protein delivery from biodegradable tyrosine-containing poly(anhydride-co-imide) microspheres. Biomaterials. 18:1997;893-901.
4. Kohn J. Single-step immunization using a controlled release, biodegradable polymer with sustained adjuvant activity. J Immunol Meth. 95:1986;31-38.
5. Franssen E., Moolenaar F., de Zeeuw D., Meijer D. Low molecular weight proteins as carriers for renal drug targeting. Naproxen coupled to lysozyme via the spacer L-lactic acid Pharma Res. 10:1993;963-969.
6. Duncan R., Dimitrijevic S., Evagorou E. The role of polymer conjugates in the diagnosis and treatment of cancer. STP Pharma Sci. 6:1996;237-263.
7. Maeda H. SMANCS and polymer-conjugated macromolecular drugs. advantages in cancer chemotherapy Adv Drug Deliv Rev. 6:1991;181-202.
8. Rimoli M., Avallone L., de Caprariis P., Galeone A., Forni F., Vandelli M. Synthesis and characterization of poly(D,L-lactic acid)-iodoxuridine conjugate. J Control Rel. 58:1999;61-68.
9. Davaran S., Hanaee J., Khosravi A. Release of 5-aminosalicylic acid from acrylic type polymeric prodrugs designed for colon-specific drug delivery. J Control Rel. 58:1999;279-287.
10. Levy G. Comparative pharmacokinetics of aspirin and acetaminophen. Arch Intern Med. 141:1981;279-281.
11. Brem H., Piantadosi S., Burger P., Walker M., Selker R., Vick N., Black K., Sisti M., Brem S., Mohr G., Muller P., Morawetz R., Schold S. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. Lancet. 345:1995;1008-1012.
12. Pouchart C. Milwaukee, WI, Aldrich, 1985.
13. Campo C., Anastasiou T., Uhrich K. Polyanhydrides. effects of ring substitution changes on polymer properties Polym Bull. 42:1999;61-68.
14. Rasmussen S., Bondesen S., Hvidberg E. 5-Aminosalicylic acid in a slow-release preparation. bioavailability, plasma level, and excretion in humans Gastroenterology. 83:1982;1062-1070.
15. Langer R. Drug delivery and targeting. Nature. 392:1998;5-10.
16. Yeh P., Berenson M., Samawitz W., Kopeckova P., Kopechek J. Site-specific drug delivery and penetration enhancement in the gastrointestinal tract. J Control Rel. 36:1995;109-124.
17. Macedo B., Uhrich K., Erdmann L. The in vivo response to a bioactive biodegradable polymer. J Dent Res. 78:1999;459.
18. Erdmann L, Macedo B, Uhrich K. Degradable poly(anhydride-ester) implants: effects of localized salicylic acid release. Biomaterials 2000, accepted for publication.
19. Das K. Sulfasalazine therapy in inflammatory bowel disease. Gastroent Clin Nuora Am. 18:1989;1-20.
20. Das K., Eastwood M. Acetylation polymorphism of sulfapyridine in patients with ulcerative colitis and Crohn's disease. Clin Pharmacol Ther. 18:1975;514-520.
21. Brown J., McGarrangh G., Parkinson T., Wingard R., Onderdonk A. A polymeric drug for treatment of inflammatory bowel disease. J Med Chem. 26:1983;1300-1307.